Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants-Reference-Cited by-同舟云学术

Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

Published:2017-03-23 Issue:8 Volume:83 Page:1835-1843
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Stolk Leo M.¹,de Vries Frank¹²³,Ebbelaar Chiel³,de Boer Anthonius³,Schalekamp Tom³,Souverein Patrick³,ten Cate-Hoek Arina⁴,Burden Andrea M.¹³

Affiliation:

1. Department of Clinical Pharmacy and Toxicology; Maastricht University Medical Centre; Maastricht the Netherlands

2. MRC Life-course Epidemiology Unit; University of Southampton; Southampton UK

3. Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology; Utrecht University; Utrecht the Netherlands

4. Department Internal Medicine; Maastricht University Medical Centre; Maastricht the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13264/fullpdf

Reference30 articles.

1. The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucleic Acids Res,2016

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

4. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

5. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants;Mayo Clinic Proceedings;2021-03

2. The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality;Rational Pharmacotherapy in Cardiology;2020-05-02

3. Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis;Clinical Gastroenterology and Hepatology;2020-04

4. Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists;International Journal of Clinical Pharmacy;2019-10-08

5. Outcome reporting from clinical trials of non-valvular atrial fibrillation treated with traditional Chinese medicine or Western medicine: a systematic review;BMJ Open;2019-08